Archives

by in
Entry Author Date Location
Shedding Baggage, Alnylam Turns a Corner 02/21/13 Boston
East Coast Life Sciences Roundup: Biogen Idec, Celgene, Alnylam, More 02/08/13 Boston
Alnylam, Lawsuit Settled, Announces $125 Million Stock Offering 01/15/13 Boston
Alnylam Inks $29M Deal With Monsanto for New Bio Tools for Farmers 08/28/12 Boston
Alnylam, Aveo, Biogen, & More Boston Life Sciences Newsmakers 01/06/12 Boston
Vertex, Ariad, Alnylam, & More Boston-Area Life Sciences Newsmakers 12/16/11 Boston
Cerulean Pharma Adds $15M to Further Nano-Drug Platform 12/15/11 Boston
Langer Nabs Cash From Rock Stars, Verastem Seeks $50M IPO, Alnylam Snags RNAi Collab, & More Boston-Area Life Sciences News 11/04/11 Boston
Alnylam and Glaxo Partner on RNAi for Vaccine Production 11/01/11 Boston
Celgene Pays Agios $20M, Lycera Adds Cambridge CEO, Getinge Buys Atrium Medical, & More Boston-Area Life Sciences News 10/07/11 Boston
RXi Splits Up, Zeo Launches Mobile Sleep-Tracking App, Karuna Licenses Schizophrenia Compounds, & More Boston-Area Life Sciences News 09/30/11 Boston
RXi Splits Into Two Public Companies After Adding Cancer Vaccine to Pipeline 09/26/11 Boston
Adventrx Shares Plummet, Pfizer Adds UC San Diego to its Network, New RNAi Center Opens, & More San Diego Life Sciences News 08/11/11 San Diego
Biogen Gets Euro Approval, BSX Shows Solid Q2, Alkermes Tries Again, & More Boston-Area Life Sciences News 07/29/11 Boston
Cerulean Shows Progress in Cancer, Tests Nano-Drug Platform in RNAi 07/27/11 Boston
Alnylam Looks to ASCO as First “Bell-Ringing” for RNAi Resurgence 05/26/11 Boston
Alnylam Inks Deal with Precision NanoSystems 04/19/11 Boston
Vertex CF Drug Delivers, Follica Patent Application Reveals Tech, RXi Buys Apthera, & More Boston-Area Life Sciences News 04/01/11 Boston
Alnylam Sued By Tekmira, Curis Cancer Drug Shows Results, Still River Gets $11.5M, & More Boston-Area Life Sciences News 03/25/11 Boston
Alnylam Named in Complaint Over RNAi Patents 03/23/11 Boston
Tekmira-Alnylam Lawsuit Centers on Drug Carrier Particles 03/18/11 Boston
Alnylam Settles One Lawsuit, Hit With Another; Living Proof Raises $16M, Tolerx/GSK Drug Fails to Meet Goal, & More Boston-Area Life Sciences News 03/18/11 Boston
Alnylam, UMass, and Others Settle RNAi Patent Litigation 03/15/11 Boston
CHiL Bought by International Rectifier, DynamicOps Gets $11M, NeuroPhage Raises $12M, & More Boston-Area Deals News 03/02/11 Boston
Mello’s RXi Pharma to Raise $8.1M 03/01/11 Boston
EyeGate Adds $6M to Series D 01/06/11 Boston
Alnylam CEO Looks to the Future, Dicerna Plumps Up Kyowa Hakko Pact, Momenta Sells $57.4M Stock Offering, & More Boston-Area Life Sciences News 12/10/10 Boston
Dicerna Expands Kyowa Hakko Pact 12/07/10 Boston
Lilly Funds Cerulean, Genzyme Sells Diagnostics Unit, Roche Ends RNAi Program, & More Boston-Area Life Sciences News 11/19/10 Boston
Alkermes Drops on FDA Rejection, Glaxo’s SR One Backs Dicerna, Biogen Reworks Genentech Alliance, & More Boston-Are Life Sciences News 10/22/10 Boston
Page 1 of 4 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.